Quinto I - Search Results

1

The aftermath of the Merck's HIV vaccine trial.

Iaccino E, Schiavone M, Fiume G, Quinto I, Scala G. Iaccino E, et al. Among authors: quinto i. Retrovirology. 2008 Jul 2;5:56. doi: 10.1186/1742-4690-5-56. Retrovirology. 2008. PMID: 18597681 Free PMC article.

2

Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.

Scala G, Quinto I, Ruocco MR, Mallardo M, Ambrosino C, Squitieri B, Tassone P, Venuta S. Scala G, et al. Among authors: quinto i. J Virol. 1993 May;67(5):2853-61. doi: 10.1128/JVI.67.5.2853-2861.1993. J Virol. 1993. PMID: 8386279 Free PMC article.

3

Regulation of HIV-1 long terminal repeats by interaction of C/EBP(NF-IL6) and NF-kappaB/Rel transcription factors.

Ruocco MR, Chen X, Ambrosino C, Dragonetti E, Liu W, Mallardo M, De Falco G, Palmieri C, Franzoso G, Quinto I, Venuta S, Scala G. Ruocco MR, et al. Among authors: quinto i. J Biol Chem. 1996 Sep 13;271(37):22479-86. doi: 10.1074/jbc.271.37.22479. J Biol Chem. 1996. PMID: 8798413 Free article.

4

High efficiency of site-directed mutagenesis mediated by a single PCR product.

Chen X, Liu W, Quinto I, Scala G. Chen X, et al. Among authors: quinto i. Nucleic Acids Res. 1997 Feb 1;25(3):682-4. doi: 10.1093/nar/25.3.682. Nucleic Acids Res. 1997. PMID: 9016615 Free PMC article.

5

HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors.

Ambrosino C, Ruocco MR, Chen X, Mallardo M, Baudi F, Trematerra S, Quinto I, Venuta S, Scala G. Ambrosino C, et al. Among authors: quinto i. J Biol Chem. 1997 Jun 6;272(23):14883-92. doi: 10.1074/jbc.272.23.14883. J Biol Chem. 1997. PMID: 9169458 Free article.

6

Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBPbeta.

Chen X, Liu W, Ambrosino C, Ruocco MR, Poli V, Romani L, Quinto I, Barbieri S, Holmes KL, Venuta S, Scala G. Chen X, et al. Among authors: quinto i. Blood. 1997 Jul 1;90(1):156-64. Blood. 1997. PMID: 9207449 Free article.

7

Potent and stable attenuation of live-HIV-1 by gain of a proteolysis-resistant inhibitor of NF-kappaB (IkappaB-alphaS32/36A) and the implications for vaccine development.

Quinto I, Mallardo M, Baldassarre F, Scala G, Englund G, Jeang KT. Quinto I, et al. J Biol Chem. 1999 Jun 18;274(25):17567-72. doi: 10.1074/jbc.274.25.17567. J Biol Chem. 1999. PMID: 10364191 Free article.

8

Direct inhibition of Bruton's tyrosine kinase by IBtk, a Btk-binding protein.

Liu W, Quinto I, Chen X, Palmieri C, Rabin RL, Schwartz OM, Nelson DL, Scala G. Liu W, et al. Among authors: quinto i. Nat Immunol. 2001 Oct;2(10):939-46. doi: 10.1038/ni1001-939. Nat Immunol. 2001. PMID: 11577348

9

Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes.

Chen X, Scala G, Quinto I, Liu W, Chun TW, Justement JS, Cohen OJ, vanCott TC, Iwanicki M, Lewis MG, Greenhouse J, Barry T, Venzon D, Fauci AS. Chen X, et al. Among authors: quinto i. Nat Med. 2001 Nov;7(11):1225-31. doi: 10.1038/nm1101-1225. Nat Med. 2001. PMID: 11689887

10

Site-directed mutagenesis mediated by a single polymerase chain reaction product.

Chen X, Liu W, Quinto I, Scala G. Chen X, et al. Among authors: quinto i. Methods Mol Biol. 2002;182:67-70. doi: 10.1385/1-59259-194-9:067. Methods Mol Biol. 2002. PMID: 11768976 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters